Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-1
Closed -$29 666
2017
Q2
$29 Hold
1
﹤0.01% 608
2017
Q1
$32 Hold
1
﹤0.01% 533
2016
Q4
$29 Hold
1
﹤0.01% 599
2016
Q3
$26 Hold
1
﹤0.01% 592
2016
Q2
$27 Sell
1
-1
-50% -$27 ﹤0.01% 515
2016
Q1
$50 Sell
2
-29
-94% -$603 ﹤0.01% 552
2015
Q4
$753 Hold
31
﹤0.01% 412
2015
Q3
$825 Hold
31
﹤0.01% 439
2015
Q2
$861 Sell
31
-2
-6% -$55 ﹤0.01% 449
2015
Q1
$881 Sell
33
-23
-41% -$652 ﹤0.01% 450
2014
Q4
$1.57K Buy
+56
New +$1.54K ﹤0.01% 464

Other funds holding USG

Exane Derivatives's USG Position: Q3 2017 in Review

Exane Derivatives sold out of Usg (USG) in Q3 2017, closing a stake of 1 share — an estimated $29 sold.

Exane Derivatives first reported a position in USG in Q4 2014 and held it in 11 quarters. The position peaked at $1.57K in Q4 2014. 231 funds tracked by Wall St. Rank hold USG as of Q3 2017.

  • Exane Derivatives reported no remaining Usg position as of Q3 2017 after selling out during the quarter.
  • Exane Derivatives sold 1 Usg share in Q3 2017, an estimated $29.
  • Exane Derivatives first reported a position in Usg in Q4 2014 and held it in 11 quarters.
  • Exane Derivatives's Usg position peaked at $1.57K in Q4 2014.
  • 231 funds tracked by Wall St. Rank held Usg as of Q3 2017.

Based on Exane Derivatives's 13F filing for Q3 2017, filed 18 Oct 2017.